Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

DionyMed Brands Inc (Sub Voting) DYMEF

DionyMed Brands Inc is a multi-state cannabis brand and distribution platform based in Canada. The company provides support to cultivators and manufacturers of medical and adult-use cannabis products. It sells branded products in every category from flower to vape cartridges, concentrates, and edibles. Geographically, it derives a majority revenue from the United States of America. The company also provides services such as Logistics Services and Software, Warehousing and Co-Packing, Manufacturi


GREY:DYMEF - Post by User

Comment by STOCKRUSon Jul 03, 2019 11:50pm
115 Views
Post# 29885577

RE:RE:Lack of Interest

RE:RE:Lack of InterestYes it's unfortunate with DYME.V ...... I was looking towards a good 2019 ....... 

I sold my shares 2 months ago for $2.50 .....

You may want to take a look at this junior producer that is under the radar. I bought in at 50-60 cents and I'm looking at $1.00-$2.00.



Here's the latest news.


Signs JV with China Pharma - Zhejiang Yatai Pharmaceutical 

Completes $11M Private Placement
 
 
BBT.C / BHHKF
 
https://benchmarkbotanics.com
 
About:  Zhejiang Yatai Pharmaceutical one of the top 500 China Enterprises
founded in 1989 researches, produces, sells, and exports pharmaceutical products, tablets, capsules, patches, powder injections in China and internationally.
 
Revenue $188.29 M USD 2018
Net Income: $30.1M USD 2018
Market Cap $ 8.525 B USD
803 employees
50 offices in 24 provinces China
GMP standards / modern pharmaceutical production techniques
2002 ISO 9001 quality certification – ISO 14001 environmental protection
 
https://en.yatai.com/
<< Previous
Bullboard Posts
Next >>